Found: 20 articles

Article Edition
A.A. Belyaev
Cerebrovascular diseases and atherosclerotic carotid stenosis: surgical and pharmacological approaches to therapy
№9 / 2019
M.V. Leonova
Deprescribing against polypragmasia: possibilities of the method
№9 / 2019
L.A. Lugovaya, L.G. Strongin, T.A. Nekrasova
CLINICAL AND PATHOGENETIC FEATURES OF MUSCLE SYMPTOMS AGAINST THE BACKGROUND OF THERAPY WITH STATINS IN PATIENTS WITH COMPENSATED HYPOTHYROIDISM
№20 / 2017
T.A. Rozhkova, V.I. Kaminnaya, M.Yu. Zubareva
THE USE OF ROSUVASTATIN IN PATIENTS WITH HYPERCHOLESTEROLEMIA (IIA AND IIB TYPE HYPERLIPDEMIA, FAMILIAL HYPERCHOLESTERINEMIA) IN CLINICAL OUTPATIENT PRACTICE
№10 / 2017
S.A. Smakotina (1), A.R. Zelendinova (1), I.N. Bondareva (2), N.V. Fomina (1), S.A. Berns (3), A.A. Golikova (3)
ATORVASTATIN IN THE PREVENTION OF CARDIOVASCULAR DISEASES IN FEMALE PATIENTS WITH RHEUMATOID ARTHRITIS
№9 / 2017
Ya.I. Ashikhmin (1), D.Yu. Schekochikhin (2)
RECOMMENDATION ON THE TREATMENT OF DYSLIPIDEMIA (ESC/EAS) 2016: FOCUS ON APPLICATION OF NON-STATIN LIPID-LOWERING THERAPY
№6 / 2017
Z.G. Luginova (1), O.A. Pogorelova (1), M.I. Tripoten (1), M.V. Koshurnikova (1), T.V. Kuznetsova (1), V.P. Masenko (1), Yu.G. Matchin (1), T.V. Balakhonova (1), A.V. Susekov (2)
MAIN RESULTS OF RANDOMIZED TRIAL "FREGAT"*: EFFECT OF SHORT-TERM INTENSIVE ROSUVASTATIN THERAPY ON CAROTID ATHEROSCLEROSIS IN PATIENTS AT VERY HIGH CARDIOVASCULAR RISK.
№18 / 2016
V.S. Nikiforov
BLOOD VISCOSITY AS A TARGET OF THERAPEUTIC INTERVENTION IN CARDIOVASCULAR PATHOLOGY
№13 / 2015
A.S. Ermolaeva, O.V. Dralova, PhD in Medical Sciences, O.D. Ostroumova, MD, M.L. Maksimov, MD
POTENTIALS FOR THE CORRECTION OF DYSLIPIDEMIA IN PATIENTS WITH ARTERIAL HYPERTENSION
№18 / 2014
F.N. Chavdar, Yu. V. Kovaleva, A.P. Maslov, M.N. Baranova, N.V. Ryzhkova, L.N. Bazhenova, Z.V. Getman
EFFECTS OF SHORT-TERM THERAPY WITH ROSUVASTATIN ON LIPID METABOLISM IN PATIENTS WITH CORONARY ARTERY DISEASE
№16 / 2014
S.V. Shalaev (1, 2), Z.M. Safiullina (1), N.A. Mikhalchuk (1)
STATINS AND THE RISK FOR NEW-ONSET DIABETES: RISK-BENEFIT RATIO. MODERN VIWES ON TARGET LIPID LEVELS IN DIABETES PATIENTS
№16 / 2014
S.V. Shalaev (1), Z.M. Safiullina (2), AA Kozlov (2)
STATINS AND ACUTE CORONARY SYNDROME: FEASIBILITY, ADVISABILITY, AND MANAGEMENT OF PATIENTS
№18 / 2013


Бионика Медиа